1 / 6

(a)

Supplementary Figure 1. Determination of minimal erythema dose (MED) in UVB irradiated hairless mice . The minimal skin erythema was observed on skin area irradiated with 120 mJ/cm 2 (1.2 mW/cm 2 x 100 s) UVB. UVB (13 W). (a). Non-UV Vehicle DIC (0.01%). (b). (c).

veda-schultz
Download Presentation

(a)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1. Determination of minimal erythema dose (MED) in UVB irradiated hairless mice. The minimal skin erythema was observed on skin area irradiated with 120 mJ/cm2 (1.2 mW/cm2x 100 s) UVB.

  2. UVB (13 W) (a) Non-UV Vehicle DIC (0.01%) (b) (c) Supplementary Figure 2. The anti-wrinkle effects of DIC, an elastase inhibitor. DIC did not attenuate wrinkle formation and degradation of collagen fibers by UVB (a) Replica photography (b) Massons’s trichrome staining for collagen fibers (c) Verhoeff staining for elastin fibers. Magnification: x 200. Bar: 200 ㎛.

  3. (b) (a) KPA(µM) Chymostatin (µg/ml) DIC (µM) - 0.8 0.16 - 10 4 - 0.8 0.16 - + + + + + + - + + + CG (1mU/ml) Intact Fn 191 97 64 51 39 28 19 (kDa) LC Fn-fr’s (c) (d) Chymostatin KPA DIC (µg/ml) (µM) (µM) 10 4 2 0.8 0.16 0.0032 0.8 0.16 - - + + + + + + + + + + + CG (1mU/ml) Pro MMP-1 Active MMP-1 Supplementary Figure 3. The inhibitory effects of KPA, chymostatin and DIC on fibronectin fragmentation and conversion of proMMP-1 to active MMP-1 in cathepsin G (CG) treated NHFs. The fragmentation of Fn was analyzed in presence of KPA, chymostatin and DIC by western blot using anti-fibronectin Ab. (a, c) Specific inhibitors of cathepsin G like KPA and chymostatin prevented Fn degradation and conversion of proMMP-1 to active MMP-1 by cathepsin G (18). (b, d) DIC, an elastase specific inhibitor, did not prevented Fn fragmentation and conversion of proMMP-1 to active MMP-1 by cathepsin G.

  4. Con CG (mU) - 1 5 10 Con Elastase (mU) - 1 5 Pro MMP-1 Active MMP-1 Supplementary Figure 4. Conversion of proMMP-1 to active MMP-1 by cathepsin G (CG) or elastase treatment in NHFs. Cathepsin G promoted the conversion of proMMP-1 to active MMP-1, but elastase did not.

  5. (a) (b) Supplementary Figure 5. Pictures of 3D dermal equivalent (3D DE). 3D DE contains collagen, fibronectin and normal human fibroblasts inDMEM medium. It changes from liquid state to gel state after incubation at 37℃ for 2 hour. (a) 3D DE in 24 well plates and (b) gel state 3D DE out 24 well plates.

  6. (a) Non UV (b) UVB+Vehicle (c) UVB+ RA (0.01%) (d) UVB+ KPA (0.025%) Supplementary Figure 6. Verhoeff staining of elastic fibers after KPA treatment. (a) Non UV control (b) UVB-irradiated vehicle treated group (c) UVB-irradiated retinoic acid treated group (d) UVB-irradiated KPA treated group. Magnification: x 200. Bar: 200 ㎛

More Related